Taurohyocholic acid acts as a potential predictor of the efficacy of tyrosine kinase inhibitors combined with programmed cell death-1 inhibitors in hepatocellular carcinoma

• Main Authors: Yue Chen (Author), Yutao Wang (Author), Jin Lei (Author), Bowen Chen (Author), Xinfeng Zhang (Author), Liangzheng Chang (Author), Zhangli Hu (Author), Yun Wang (Author), Yinying Lu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2024-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background and aims: Tyrosine kinase inhibitors (TKIs) combined with programmed cell death protein-1 (PD-1) have significantly improved survival in patients with unresectable hepatocellular carcinoma (uHCC), but effective biomarkers to predict treatment efficacy are lacking. Peripheral blood bile ac...